Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B R DAVIS

Showing results (131-140 of 154) with videos related to

Pageof 16
Sort By:
Circulation|November 15, 1996
Serum lipids and incidence of coronary heart disease. Findings from the Systolic Hypertension in the Elderly Program (SHEP)P H Frost, B R Davis, A J Burlando, et al.
Journal of the American College of Cardiology|July 10, 1999
Pravastatin prevents clinical events in revascularized patients with average cholesterol concentrations. Cholesterol and Recurrent Events CARE InvestigatorsG C Flaker, J W Warnica, F M Sacks, et al.
The New England Journal of Medicine|September 13, 1992
Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE InvestigatorsM A Pfeffer, E Braunwald, L A Moyé, et al.
Journal of Clinical Microbiology|January 1, 1985
Escherichia fergusonii and Enterobacter taylorae, two new species of Enterobacteriaceae isolated from clinical specimensJ J Farmer, G R Fanning, B R Davis, et al.
European Heart Journal|May 1, 1994
Uniformity of captopril benefit in the SAVE Study: subgroup analysis. Survival and Ventricular Enlargement StudyL A Moyé, M A Pfeffer, C C Wun, et al.
The Pharmacogenomics Journal|June 6, 2012
RYR3 gene polymorphisms and cardiovascular disease outcomes in the context of antihypertensive treatmentA I Lynch, M R Irvin, E Boerwinkle, et al.
JAMA|July 25, 2000
Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: the Systolic Hypertension in the Elderly Program (SHEP)H M Perry, B R Davis, T R Price, et al.
Journal of Human Hypertension|January 22, 2016
The effects of genes implicated in cardiovascular disease on blood pressure response to treatment among treatment-naive hypertensive African Americans in the GenHAT studyA N Do, A I Lynch, S A Claas, et al.
Controlled Clinical Trials|April 1, 1991
Operational aspects of terminating randomization in the Multicenter Trial of Cryotherapy for Retinopathy of Prematurity. Cryotherapy for Retinopathy of Prematurity Cooperative GroupE A Palmer, R J Hardy, B R Davis, et al.
Circulation|October 1, 1994
Effects of captopril on ischemic events after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. SAVE InvestigatorsJ D Rutherford, M A Pfeffer, L A Moyé, et al.
Pageof 16

Showing results (131-140 of 154) with videos related to

Sort By:
Pageof 16
Circulation|November 15, 1996
Serum lipids and incidence of coronary heart disease. Findings from the Systolic Hypertension in the Elderly Program (SHEP)P H Frost, B R Davis, A J Burlando, et al.
Journal of the American College of Cardiology|July 10, 1999
Pravastatin prevents clinical events in revascularized patients with average cholesterol concentrations. Cholesterol and Recurrent Events CARE InvestigatorsG C Flaker, J W Warnica, F M Sacks, et al.
The New England Journal of Medicine|September 13, 1992
Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE InvestigatorsM A Pfeffer, E Braunwald, L A Moyé, et al.
Journal of Clinical Microbiology|January 1, 1985
Escherichia fergusonii and Enterobacter taylorae, two new species of Enterobacteriaceae isolated from clinical specimensJ J Farmer, G R Fanning, B R Davis, et al.
European Heart Journal|May 1, 1994
Uniformity of captopril benefit in the SAVE Study: subgroup analysis. Survival and Ventricular Enlargement StudyL A Moyé, M A Pfeffer, C C Wun, et al.
The Pharmacogenomics Journal|June 6, 2012
RYR3 gene polymorphisms and cardiovascular disease outcomes in the context of antihypertensive treatmentA I Lynch, M R Irvin, E Boerwinkle, et al.
JAMA|July 25, 2000
Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: the Systolic Hypertension in the Elderly Program (SHEP)H M Perry, B R Davis, T R Price, et al.
Journal of Human Hypertension|January 22, 2016
The effects of genes implicated in cardiovascular disease on blood pressure response to treatment among treatment-naive hypertensive African Americans in the GenHAT studyA N Do, A I Lynch, S A Claas, et al.
Controlled Clinical Trials|April 1, 1991
Operational aspects of terminating randomization in the Multicenter Trial of Cryotherapy for Retinopathy of Prematurity. Cryotherapy for Retinopathy of Prematurity Cooperative GroupE A Palmer, R J Hardy, B R Davis, et al.
Circulation|October 1, 1994
Effects of captopril on ischemic events after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. SAVE InvestigatorsJ D Rutherford, M A Pfeffer, L A Moyé, et al.
Pageof 16